Skip to main content

Data Requests to Use Johnson and Johnson Data

Request listing updated daily

Withdrawn Requests

The following data requests could not be fulfilled due to patient privacy concerns, data element availability, data security concerns, or lack of research proposal clarity. The YODA Project posts withdrawn/unapproved proposals at the time the decision is made.

26 Results
YODA PROJECT Protocol Number2020-4423
Product(s) of Interest
PREZISTA® (Darunavir)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorDéborah Hirt
Service de pharmacologie - Hopital Cochin
YODA PROJECT Protocol Number2020-4359
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorDaniele Modonutti
Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA;
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2020-4319
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorKenichiro Sato
University of Tokyo
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2020-4243
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided5
Withdrawn/Closed
Principal InvestigatorMami Seki
Shimane University School of Medicine, Department of Medical Informatics
Reports & Publications
Request originally approved but subsequently withdrawn: the Data Partner has terminated their license for the requested product
YODA PROJECT Protocol Number2019-4133
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorJunko Takeshita
University of Pennsylvania
Reports & Publications
*Request originally approved but subsequently withdrawn: data from other sources not received
YODA PROJECT Protocol Number2019-4132
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorMaureen Dubreuil
Boston University School of Medicine
Reports & Publications
*Request withdrawn prior to approval determination: Data Partner supports access through independent process
YODA PROJECT Protocol Number2019-4023
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorBenjamin Gandesbery
Barnes-Jewish Hospital
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2019-4001
Product(s) of Interest
HEALOS® (HEALOS and Leopard Cage)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3864
Product(s) of Interest
EDURANT® (Rilpivirine), PROCRIT® (Epoetin alfa), PREZISTA® (Darunavir)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorKin Wah Fung
National Library of Medicine
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2019-3842
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorAdam Cheifetz
Beth Israel Deaconess Medical Center
Reports & Publications
*Request originally approved but subsequently withdrawn: anticipated insufficient values
YODA PROJECT Protocol Number2019-3840
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorMaya Koren-Michowitz
Shamir (Assaf Harofe Medical Center)
Reports & Publications
*Request withdrawn prior to approval determination: ECG scans not available due to patient privacy concerns
YODA PROJECT Protocol Number2018-2946
Product(s) of Interest
YONDELIS® (Trabectedin)
No. Trials Provided4
Withdrawn/Closed
Principal InvestigatorSujana Movva
Fox Chase Cancer Center
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2018-2746
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorKT Park
Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2018-2711
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorIñaki F. Trocóniz
Navarra University
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2016-1107
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided7
Unknown - Revoked
Principal InvestigatorFrank Scott
University of Colorado Anschutz Medical Campus
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-1026
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided8
Withdrawn/Closed
Principal InvestigatorIssa Dahabreh
Brown University
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2016-0994
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAlex Sturm
University of California, Los Angeles
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2016-0969
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided4
Unknown - Revoked
Principal InvestigatorSuzanne Reeves
University College London
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-0738
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorChristophe Moreno
CUB Hôpital Erasme
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2015-0592
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone), RAZADYNE® (Galantamine), INVEGA SUSTENNA® (Paliperidone palmitate), CONCERTA® (Methylphenidate HCl)
No. Trials Provided38
Withdrawn/Closed
Principal InvestigatorYang Yan
Holmusk
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2015-0556
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorSigrid Nelson
Robarts Clinical Trials
Reports & Publications
*Request withdrawn prior to approval determination: endoscopy videos not available due to patient privacy concerns
YODA PROJECT Protocol Number2015-0539
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAlex Sturm
University of California, Los Angeles
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested
YODA PROJECT Protocol Number2015-0501
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAnthony Otley
IWK Health Centre
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested
YODA PROJECT Protocol Number2015-0406
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorNicola Schieda
The Ottawa Hospital - The University of Ottawa
Reports & Publications
*Request originally approved but subsequently withdrawn: CT scans not available due to patient privacy concerns
YODA PROJECT Protocol Number2014-0333
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorGuru Sonpavde
University of Alabama, Birmingham (UAB) School of Medicine
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2014-0287
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorWilliam J. Sandborn
University of California San Diego
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested